173 related articles for article (PubMed ID: 17951061)
1. Synthesis and structure-activity relationships of N-{1-[(6-fluoro-2-naphthyl)methyl]piperidin-4-yl}benzamide derivatives as novel CCR3 antagonists.
Sato I; Morihira K; Inami H; Kubota H; Morokata T; Suzuki K; Hamada N; Iura Y; Nitta A; Imaoka T; Takahashi T; Takeuchi M; Ohta M; Tsukamoto S
Bioorg Med Chem; 2008 Jan; 16(1):144-56. PubMed ID: 17951061
[TBL] [Abstract][Full Text] [Related]
2. Design and synthesis of 6-fluoro-2-naphthyl derivatives as novel CCR3 antagonists with reduced CYP2D6 inhibition.
Sato I; Morihira K; Inami H; Kubota H; Morokata T; Suzuki K; Iura Y; Nitta A; Imaoka T; Takahashi T; Takeuchi M; Ohta M; Tsukamoto S
Bioorg Med Chem; 2008 Sep; 16(18):8607-18. PubMed ID: 18752960
[TBL] [Abstract][Full Text] [Related]
3. A novel, selective, and orally available antagonist for CC chemokine receptor 3.
Morokata T; Suzuki K; Masunaga Y; Taguchi K; Morihira K; Sato I; Fujii M; Takizawa S; Torii Y; Yamamoto N; Kaneko M; Yamada T; Takahashi K; Shimizu Y
J Pharmacol Exp Ther; 2006 Apr; 317(1):244-50. PubMed ID: 16339911
[TBL] [Abstract][Full Text] [Related]
4. Small molecule antagonists for chemokine CCR3 receptors.
Willems LI; Ijzerman AP
Med Res Rev; 2010 Sep; 30(5):778-817. PubMed ID: 19967721
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, biological evaluation, and metabolic stability of acrylamide derivatives as novel CCR3 antagonists.
Sato I; Morihira K; Inami H; Kubota H; Morokata T; Suzuki K; Ohno K; Iura Y; Nitta A; Imaoka T; Takahashi T; Takeuchi M; Ohta M; Tsukamoto S
Bioorg Med Chem; 2009 Aug; 17(16):5989-6002. PubMed ID: 19620010
[TBL] [Abstract][Full Text] [Related]
6. N-Arylalkylpiperidine urea derivatives as CC chemokine receptor-3 (CCR3) antagonists.
Batt DG; Houghton GC; Roderick J; Santella JB; Wacker DA; Welch PK; Orlovsky YI; Wadman EA; Trzaskos JM; Davies P; Decicco CP; Carter PH
Bioorg Med Chem Lett; 2005 Feb; 15(3):787-91. PubMed ID: 15664858
[TBL] [Abstract][Full Text] [Related]
7. Discovery and structure-activity relationships of urea derivatives as potent and novel CCR3 antagonists.
Nitta A; Iura Y; Tomioka H; Sato I; Morihira K; Kubota H; Morokata T; Takeuchi M; Ohta M; Tsukamoto S; Imaoka T; Takahashi T
Bioorg Med Chem Lett; 2012 Aug; 22(15):4951-4. PubMed ID: 22749826
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of benzamide derivatives as TRPV1 antagonists.
Shishido Y; Jinno M; Ikeda T; Ito F; Sudo M; Makita N; Ohta A; Iki-Taki A; Ohmi T; Kanai Y; Tamura T; Shimojo M
Bioorg Med Chem Lett; 2008 Feb; 18(3):1072-8. PubMed ID: 18155908
[TBL] [Abstract][Full Text] [Related]
9. First pharmacophore model of CCR3 receptor antagonists and its homology model-assisted, stepwise virtual screening.
Jain V; Saravanan P; Arvind A; Mohan CG
Chem Biol Drug Des; 2011 May; 77(5):373-87. PubMed ID: 21284830
[TBL] [Abstract][Full Text] [Related]
10. Biarylcarboxybenzamide derivatives as potent vanilloid receptor (VR1) antagonistic ligands.
Park HG; Choi JY; Kim MH; Choi SH; Park MK; Lee J; Suh YG; Cho H; Oh U; Kim HD; Joo YH; Shin SS; Kim JK; Jeong YS; Koh HJ; Park YH; Jew SS
Bioorg Med Chem Lett; 2005 Feb; 15(3):631-4. PubMed ID: 15664827
[TBL] [Abstract][Full Text] [Related]
11. Pyrrolidinohydroquinazolines--a novel class of CCR3 modulators.
Anderskewitz R; Bauer R; Bodenbach G; Gester D; Gramlich B; Morschhäuser G; Birke FW
Bioorg Med Chem Lett; 2005 Feb; 15(3):669-73. PubMed ID: 15664834
[TBL] [Abstract][Full Text] [Related]
12. The allergy-associated chemokine receptors CCR3 and CCR5 can be inactivated by the modified chemokine NNY-CCL11.
Manns J; Rieder S; Escher S; Eilers B; Forssmann WG; Elsner J; Forssmann U
Allergy; 2007 Jan; 62(1):17-24. PubMed ID: 17156337
[TBL] [Abstract][Full Text] [Related]
13. Discovering benzamide derivatives as glycogen phosphorylase inhibitors and their binding site at the enzyme.
Chen L; Li H; Liu J; Zhang L; Liu H; Jiang H
Bioorg Med Chem; 2007 Nov; 15(21):6763-74. PubMed ID: 17719791
[TBL] [Abstract][Full Text] [Related]
14. CCR3 antagonists: a potential new therapy for the treatment of asthma. Discovery and structure-activity relationships.
Wacker DA; Santella JB; Gardner DS; Varnes JG; Estrella M; DeLucca GV; Ko SS; Tanabe K; Watson PS; Welch PK; Covington M; Stowell NC; Wadman EA; Davies P; Solomon KA; Newton RC; Trainor GL; Friedman SM; Decicco CP; Duncia JV
Bioorg Med Chem Lett; 2002 Jul; 12(13):1785-9. PubMed ID: 12067561
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and histone deacetylase inhibitory activity of new benzamide derivatives.
Suzuki T; Ando T; Tsuchiya K; Fukazawa N; Saito A; Mariko Y; Yamashita T; Nakanishi O
J Med Chem; 1999 Jul; 42(15):3001-3. PubMed ID: 10425110
[TBL] [Abstract][Full Text] [Related]
16. 2,4-Disubstituted piperidines as selective CC chemokine receptor 3 (CCR3) antagonists: synthesis and selectivity.
Watson PS; Jiang B; Harrison K; Asakawa N; Welch PK; Covington M; Stowell NC; Wadman EA; Davies P; Solomon KA; Newton RC; Trainor GL; Friedman SM; Decicco CP; Ko SS
Bioorg Med Chem Lett; 2006 Nov; 16(21):5695-9. PubMed ID: 16931001
[TBL] [Abstract][Full Text] [Related]
17. N-(4-{[4-(1H-Benzoimidazol-2-yl)-arylamino]-methyl}-phenyl)-benzamide derivatives as small molecule heparanase inhibitors.
Xu YJ; Miao HQ; Pan W; Navarro EC; Tonra JR; Mitelman S; Camara MM; Deevi DS; Kiselyov AS; Kussie P; Wong WC; Liu H
Bioorg Med Chem Lett; 2006 Jan; 16(2):404-8. PubMed ID: 16246551
[TBL] [Abstract][Full Text] [Related]
18. The synthesis of substituted bipiperidine amide compounds as CCR3 ligands: antagonists versus agonists.
Ting PC; Umland SP; Aslanian R; Cao J; Garlisi CG; Huang Y; Jakway J; Liu Z; Shah H; Tian F; Wan Y; Shih NY
Bioorg Med Chem Lett; 2005 Jun; 15(12):3020-3. PubMed ID: 15908209
[TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of 3,5-disubstituted benzamide analogues of DNK333 as dual NK1/NK2 receptor probes.
Swarna VM; Undem BJ; Korlipara VL
Bioorg Med Chem Lett; 2007 Feb; 17(4):890-4. PubMed ID: 17169559
[TBL] [Abstract][Full Text] [Related]
20. N1-Benzoyl-N2-[1-(1-naphthyl)ethyl]-trans-1,2-diaminocyclohexanes: Development of 4-chlorophenylcarboxamide (calhex 231) as a new calcium sensing receptor ligand demonstrating potent calcilytic activity.
Kessler A; Faure H; Petrel C; Rognan D; Césario M; Ruat M; Dauban P; Dodd RH
J Med Chem; 2006 Aug; 49(17):5119-28. PubMed ID: 16913701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
